Biotransformation in man and clinical toxicity of volatile anesthetics

Insights

Delayed toxic reactions from general anesthesia stem from drug metabolism. Strategies to improve anesthetic safety include developing resistant drugs or inhibitors, and identifying susceptible patients.

Area of Science:

  • Anesthesiology
  • Toxicology
  • Pharmacology

Background:

  • Delayed toxic reactions after general anesthesia are linked to anesthetic drug biotransformation.
  • Metabolites of volatile anesthetics can cause irreversible intracellular binding, potentially leading to hepatic necrosis.
  • Toxic metabolite production is another significant cause of adverse anesthetic reactions.

Purpose of the Study:

  • To explore the mechanisms of delayed toxic reactions following general anesthesia.
  • To identify factors contributing to hepatic necrosis and nephrotoxicity.
  • To suggest strategies for improving the safety of general anesthesia.

Main Methods:

  • Review of existing literature on anesthetic drug metabolism and toxicity.
  • Correlation analysis of nephrotoxicity with blood fluoride and urinary oxalate levels.
  • Examination of enzyme induction effects on anesthetic toxicity using animal models.

Main Results:

  • Extensively metabolized volatile anesthetics can produce metabolites causing hepatic necrosis.
  • Methoxyflurane-induced nephrotoxicity correlates with blood fluoride and urinary oxalate.
  • Enzyme induction, demonstrated in monkeys, can increase toxic metabolite production, turning a safe anesthetic into a lethal one.

Conclusions:

  • Anesthetic safety can be enhanced by developing biotransformation-resistant anesthetics or inhibitors.
  • Identifying patients susceptible to delayed toxic reactions is crucial for improving anesthetic safety.
  • Further research into enzyme induction and patient susceptibility is warranted.

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...